ALLIED HEALTHCARE PRODUCTS (AHPI) Fundamental Analysis & Valuation
NASDAQ:AHPI • US0192222075
Current stock price
0.5501 USD
+0.02 (+3.58%)
At close:
0.53 USD
-0.02 (-3.65%)
After Hours:
This AHPI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. AHPI Profitability Analysis
1.1 Basic Checks
- AHPI had negative earnings in the past year.
- In the past year AHPI has reported a negative cash flow from operations.
1.2 Ratios
- AHPI has negative profitability rations, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- AHPI's Gross Margin of 9.34% is on the low side compared to the rest of the industry. AHPI is outperformed by 81.94% of its industry peers.
- In the last couple of years the Gross Margin of AHPI has declined.
- AHPI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 9.34% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.28%
GM growth 5Y-13.86%
2. AHPI Health Analysis
2.1 Basic Checks
- AHPI does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, AHPI has about the same amount of shares outstanding.
- AHPI has a worse debt/assets ratio than last year.
2.2 Solvency
- Based on the Altman-Z score of -0.28, we must say that AHPI is in the distress zone and has some risk of bankruptcy.
- The Altman-Z score of AHPI (-0.28) is comparable to the rest of the industry.
- AHPI has a Debt/Equity ratio of 1.52. This is a high value indicating a heavy dependency on external financing.
- AHPI's Debt to Equity ratio of 1.52 is on the low side compared to the rest of the industry. AHPI is outperformed by 84.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.52 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.28 |
ROIC/WACCN/A
WACC5.72%
2.3 Liquidity
- AHPI has a Current Ratio of 2.69. This indicates that AHPI is financially healthy and has no problem in meeting its short term obligations.
- AHPI's Current ratio of 2.69 is on the low side compared to the rest of the industry. AHPI is outperformed by 64.35% of its industry peers.
- A Quick Ratio of 1.27 indicates that AHPI should not have too much problems paying its short term obligations.
- AHPI's Quick ratio of 1.27 is on the low side compared to the rest of the industry. AHPI is outperformed by 77.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.69 | ||
| Quick Ratio | 1.27 |
3. AHPI Growth Analysis
3.1 Past
- The earnings per share for AHPI have decreased strongly by -420.62% in the last year.
- AHPI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -25.45%.
- AHPI shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.19% yearly.
EPS 1Y (TTM)-420.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-226.18%
Revenue 1Y (TTM)-25.45%
Revenue growth 3Y-4.85%
Revenue growth 5Y-4.19%
Sales Q2Q%-14.32%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. AHPI Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for AHPI. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. AHPI Dividend Analysis
5.1 Amount
- AHPI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AHPI Fundamentals: All Metrics, Ratios and Statistics
0.5501
+0.02 (+3.58%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)02-13 2023-02-13/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners2.27%
Ins Owner Change0%
Market Cap2.21M
Revenue(TTM)27.05M
Net Income(TTM)-5.36M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.08 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.42 | ||
| P/tB | 0.42 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.34
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.04
FCFYN/A
OCF(TTM)-1.02
OCFYN/A
SpS6.74
BVpS1.3
TBVpS1.3
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 9.34% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.28%
GM growth 5Y-13.86%
F-Score2
Asset Turnover1.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.52 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 16.63% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.69 | ||
| Quick Ratio | 1.27 | ||
| Altman-Z | -0.28 |
F-Score2
WACC5.72%
ROIC/WACCN/A
Cap/Depr(3y)48.49%
Cap/Depr(5y)29.1%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-420.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-226.18%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-25.45%
Revenue growth 3Y-4.85%
Revenue growth 5Y-4.19%
Sales Q2Q%-14.32%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-757.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-8.25%
OCF growth 3YN/A
OCF growth 5YN/A
ALLIED HEALTHCARE PRODUCTS / AHPI Fundamental Analysis FAQ
What is the fundamental rating for AHPI stock?
ChartMill assigns a fundamental rating of 1 / 10 to AHPI.
What is the valuation status of ALLIED HEALTHCARE PRODUCTS (AHPI) stock?
ChartMill assigns a valuation rating of 3 / 10 to ALLIED HEALTHCARE PRODUCTS (AHPI). This can be considered as Overvalued.
Can you provide the profitability details for ALLIED HEALTHCARE PRODUCTS?
ALLIED HEALTHCARE PRODUCTS (AHPI) has a profitability rating of 0 / 10.
What is the financial health of ALLIED HEALTHCARE PRODUCTS (AHPI) stock?
The financial health rating of ALLIED HEALTHCARE PRODUCTS (AHPI) is 1 / 10.